Tags |
|
|
Links |
|
|
Just Other Articles - Organization Performance - Effort vs Results
Business owners and executives are frequently frustrated because, although their employees are constantly busy and hard-working doing what they have been instructed to do, their companies do not achieve the results that were
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
planned. In other years, results are achieved more because of good fortune and unexpected events and less due to employee’s efforts. How can they truly judge the effectiveness of their organization?
In entrepreneurial comp
In entrepreneurial comp
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
nies, organizations are usually built around the strengths and skills of the founders and early employees. As these businesses grow, additional responsibilities are added to those employees who are doing a good job and when
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
hey become overloaded new employees are added. Over time, these organizations are destined to reach limitations and obstacles because their structure was not planned to extend beyond the needs of a small company. In larger
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
companies, the organization structure may be gradually altered by adopting one popular management program after another that emphasizes only one goal of the business.
In any business, there are defined functions that must be
In any business, there are defined functions that must be
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
accomplished if the company is to be successful. When developing an effective organization, a structure should be designed around these critical functions and not the particular skills and interests of the individuals curren
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
ly working there. Without delineating the functional responsibilities in the employee job assignments, it is difficult to assess what is working well and where organizational changes need to be made in the future.
The same
The same
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
is true when assessing the performance of individuals in the organization. Many times, it is difficult to distinguish between an individual’s effort expended and results achieved. This is generally because management is con
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
used about responsibility for the different parts of organization performance. The accountability for performance effort and results need to be addressed when employee job descriptions are written and when the performance st
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
ndards are assigned for the year.
Top management is responsible to develop a comprehensive strategic plan for the business that defines the goals that will satisfy the expectations of their organization’s customers, sharehol
Top management is responsible to develop a comprehensive strategic plan for the business that defines the goals that will satisfy the expectations of their organization’s customers, sharehol
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
ers, financial institutions and employees. Goals such as revenue growth, profitability, return on investment, customer and employee satisfaction must be identified by the appropriate functional area of responsibility. Goals
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
should be set for the different planning time frames (one year, three years, five years), and they must be objectively measurable. Once established and adopted by the management team, these goals need to be clearly communic
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
ted throughout the organization and progress reported periodically.
Top management also has the responsibility to determine the specific strategic focus and resources that will be employed to achieve these goals or results.
Top management also has the responsibility to determine the specific strategic focus and resources that will be employed to achieve these goals or results.
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
This requires a thorough analysis and understanding of the market characteristics, customer demands, product requirements and competitive forces. It requires making some hard choices as to where to concentrate the organizati
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
on’s limited resources to maximize its advantages and competitive strengths. Resources in the form of adequate finances, facilities, equipment and personnel must be secured and in place if the organization is to be able to a
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
complish the results within the planned timeline.
With the resources available and the business strategies identified, a tactical action plan can be established for each functional area and each key employee in that function
With the resources available and the business strategies identified, a tactical action plan can be established for each functional area and each key employee in that function
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
l area. It is now that specific performance standards or management by objectives can be established to follow the agreed strategic direction to achieve a defined result in a specified time period.
It is only now that it is
It is only now that it is
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
possible to accurately distinguish between individual effort or performance in the accomplishment of specified tactical assignments and the actual results that may be achieved because of unforeseen or fortuitous developments
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
outside the control of the individual. It is also important to evaluate if the results added value and are cost effective.
This is also where it is possible to distinguish between an individual employee’s poor performance e
This is also where it is possible to distinguish between an individual employee’s poor performance e
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
fort to implement a tactical plan and achieve a specific result and possibly top management’s poor planning when choosing a strategy or failing to provide adequate resources that made the hope of achieving the goal improbable
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.justotherarticles.org.ua/article/20784/justotherarticles-Organization-Performance--Effort-vs-Results.html">Organization Performance - Effort vs Results</a>
BB link (for phorums):
[url=http://www.justotherarticles.org.ua/article/20784/justotherarticles-Organization-Performance--Effort-vs-Results.html]Organization Performance - Effort vs Results[/url]
Related Articles:
Interior Design Jobs - Career Opportunities for Artistic People
Writing The Winning Executive Summary I-What Do The Judges Want?
8 Non-profit Fundraising Ideas - From a Donor's Perspective PART 1
Bookmark it:
|